Divanshi Suryavanshi (2025) “INSULYSIN INHIBITORS AS NOVEL ANTI-DIABETIC AGENTS: FROM COMPUTATIONAL DESIGN TO PRE-CLINICAL VALIDATION”, Journal of Population Therapeutics and Clinical Pharmacology, 32(8), pp. 1242–1257. doi:10.53555/npva0c18.